1st June 2018
We are very pleased to announce that Mateja Vidic has completed and been awarded her PhD for the Development of DNA Aptamers Specific for Non-Small Cell Lung Cancer by the University of Ljubljana, Slovenija. Her experience in aptamer selection and application is a valuable asset to our lab and we are very proud […]
5th March, 2018
Aptamer Group Ltd is delighted to announce the appointment of Paul Armstrong to our board, effective immediately, as Non-executive Director. Paul comes to us with a strong background in the antibody and research reagents sector, most recently with Abcam. Paul will advise us on our strategic direction in our commercial operations and overall […]
Working at Aptamer Group:
The continued success of Aptamer Group means that the scientific team continues to grow. One member who joined us this summer is Katriona. Now she has had the chance to establish herself, we took the opportunity to catch up with her.
Hi Katriona, please tell us a little about yourself.
I am currently a […]
19th September, 2017
An insight into working at Aptamer Group
Mateja joined Aptamer Group in August as a Selection Technician. Now she has had the chance to settle in and become established in her role, we took the opportunity to catch up with her.
Can you tell us a bit about your Ph.D.?
I have just finished the research […]
19th June 2017
Despite the current volatile environment for small businesses, Aptamer Group continues to grow and prosper. We are regularly delivering aptamers selected against small molecule and protein targets to our customers for a range of applications. The Aptamer Group is at an important stage of its evolution and in addition to collaborating with global […]
